Representation and Medication Use in Juvenile Idiopathic Arthritis
NCT ID: NCT03892135
Last Updated: 2019-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2017-04-01
2017-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
NCT05696340
Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis
NCT03731520
(1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy
NCT03984669
Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis
NCT06806774
An Investigation Into the Relationship Between Dietary Intake and Health-related Quality of Life in Children and Young People With Juvenile Idiopathic Arthritis
NCT04903067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physicians
3 paediatricians and 3 rheumatologists
Interviews with Physicians
Interviews with Physicians
Parents
Parents
Interviews with parents of children with juvenile idiopathic arthritis
Interviews with parents of children with juvenile idiopathic arthritis
Children
Children
Interviews with children with juvenile idiopathic arthritis
Interviews with children with juvenile idiopathic arthritis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interviews with parents of children with juvenile idiopathic arthritis
Interviews with parents of children with juvenile idiopathic arthritis
Interviews with children with juvenile idiopathic arthritis
Interviews with children with juvenile idiopathic arthritis
Interviews with Physicians
Interviews with Physicians
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all treatment type (NSAIDs, MTX, bDMARDs)
Exclusion Criteria
1 Year
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research department, unknowns, Strategic & innovation consulting, Paris (anthropologists)
UNKNOWN
NORDIC pharma (funding)
UNKNOWN
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-David COHEN, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL19_0171
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.